Sonova has had a PPA conducted for the acquisition of AudioNova
In September 2016, Sonova, the world’s leading provider of hearing solutions, acquired AudioNova. Subsequent to the transaction, a purchase price allocation (PPA) was conducted for accounting purposes.
Sonova, headquartered in Stäfa, Switzerland, is the leading provider of innovative hearing care solutions. The group operates through its core business brands Phonak, Unitron, Hansaton and Advanced Bionics. Sonova offers its customers one of the most comprehensive product portfolios in the industry – from hearing instruments to cochlear implants and wireless communication solutions. Founded in 1947, the group is currently present in over 100 countries across the globe and has a workforce of over 14,000 dedicated employees.
AudioNova is one of Europe’s leading hearing aid retailers and service providers. With its highly qualified staff, including 1,600 acousticians, the company assists its clients with the selection of the best hearing solution for their needs, ensuring actual use through continuous support, thus improving quality of life through better hearing. In addition to AudioNova, the group also operates under brands such as Audium, AuditionSanté, Boots Hearingcare, Connect Hearing, Fiebing, Geers, Hansaton, Lapperre, Lindacher, Schoonenberg, Triton and Vitakustik.
Oaklins' team in Switzerland advised Sonova during the post-transaction phase and produced a PPA report in accordance with IFRS 3. The report contained the allocation of the consideration paid to all identifiable assets acquired and liabilities assumed.
Thomas Lenz
Senior Manager Corporate Controlling, Sonova
Talk to the deal team
Related deals
Xiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn moreSaideep Healthcare and Research has raised equity
Saideep Healthcare and Research Private Limited has successfully completed a fundraising. This funding will help Saideep become a leading healthcare brand, offering advanced specialties across the region. The funds from this collaboration will be used to diversify into new and complex specialties, expand infrastructure and meet the growing demand for high-quality healthcare services in Western India.
Learn more